无标定检测市场规模、份额、成长分析、按产品、按技术、按应用、按最终用户、按地区 - 行业预测，2024-2031 年

2022年全球无标定检测市场规模为15亿美元，从2023年的16.2亿美元成长到2031年的30.5亿美元，在预测期内（2024-2031年）预计将以复合年增长率成长。 。

由于萤光和其他技术的进步，无需使用标籤即可研究生物分子交互作用，预计无标定检测系统市场将显着成长。这些系统有助于快速、即时的药物发现，主要用于生化和基于细胞的测定。从 2021 年到 2028 年，旨在加强药物发现计画的产学界合作激增，预计将进一步推动市场扩张。此外，研究经费的增加和无标定技术固有的高灵敏度将支持成长。扩大製药和生物技术研发领域，加上最终用户对无标定方法优势的认识不断增强，确保了预测期内市场的强劲发展。

目录

介绍

• 研究目的
• 调查范围
• 定义

调查方法

• 资讯采购
• 二手资料和主要资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 按细分市场的机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制因素和挑战
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2023）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 价格分析
• 技术进步
• 监管环境
• 专利分析
• 案例研究

无标定检测市场规模：依产品及复合年增长率（2024-2031）

• 市场概况
• 消耗品
  • 生物感测器晶片
  • 微孔盘
• 装置

无标定检测市场规模：依技术及复合年增长率（2024-2031）

• 市场概况
• 生物层干涉测量法
• 差示扫描量热法
• 等温滴定量热法
• 表面等离子体共振
• 质谱分析
• 其他 LFD 技术

无标定检测市场规模：按应用和复合年增长率（2024-2031）

• 市场概况
• 结合动力学
• 键动态
• 内源性受体检测
• 点击确认
• 潜在客户世代
• 其他的

按最终用户无标定检测市场规模和复合年增长率（2024-2031）

• 市场概况
• 製药和生物技术公司
• 学术研究所
• 合约调查机构

无标定检测市场规模及复合年增长率（2024-2031）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东/非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东/非洲

竞争资讯

• 前5名企业对比
• 主要企业市场定位（2023年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2023）
• 主要企业简介
  • 公司简介
  • 产品系列分析
  • 按细分市场分類的份额分析
  • 收益与前一年同期比较（2021-2023）

主要企业简介

• Agilent Technologies, Inc.（USA）
• Danaher Corporation（USA）
• PerkinElmer, Inc.（USA）
• GE Healthcare（USA）
• Thermo Fisher Scientific Inc.（USA）
• Bio-Rad Laboratories, Inc.（USA）
• F. Hoffmann-La Roche AG（Switzerland）
• Horiba, Ltd.（Japan）
• Malvern Panalytical Ltd.（UK）
• Bruker Corporation（USA）
• Waters Corporation（USA）
• Shimadzu Corporation（Japan）
• Corning Incorporated（USA）
• Hitachi High-Tech Corporation（Japan）
• Molecular Devices, LLC（USA）
• Sartorius AG（Germany）
• BiOptix Analytical LLC（USA）
• Attana AB（Sweden）
• XanTec Bioanalytics GmbH（Germany）

结论和建议

Global Label Free Detection Market size was valued at USD 1.5 billion in 2022 and is poised to grow from USD 1.62 billion in 2023 to USD 3.05 billion by 2031, growing at a CAGR of 8.2% during the forecast period (2024-2031).

The label-free detection systems market is poised for significant growth, driven by advancements in technology that enable the study of biomolecular interactions without auto-fluorescence or labels. These systems facilitate rapid, real-time drug discovery and are predominantly utilized in biochemical and cell-based assays. From 2021 to 2028, a surge in academic-industrial partnerships aimed at bolstering drug discovery programs is expected to further propel market expansion. Additionally, increased funding for research and the inherent high sensitivity of label-free technologies will support growth. The expanding pharmaceutical and biotechnology R&D landscape, coupled with rising awareness of label-free methods' advantages among end-users, will ensure robust market development throughout the forecast period.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Label Free Detection market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Label Free Detection Market Segmental Analysis

Global Label Free Detection Market is segmented by product, technology, application, end-user and region. Based on product, the market is segmented into consumables and instruments. Based on technology, the market is segmented into bio-layer interferometry, differential scanning calorimetry, isothermal titration calorimetry, surface plasmon resonance, mass spectrometry and other LFD technologies. Based on application, the market is segmented into binding kinetics, binding thermodynamics, endogenous receptor detection, hit confirmation, lead generation and other. Based on end-user, the market is segmented into pharmaceutical & biotechnology companies, academic & research institutes and contract research organizations. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Label Free Detection Market

The Global Label Free Detection market is poised for significant growth, driven largely by advancements in life sciences and the emergence of more sensitive technologies that do not rely on markers. The expansion of life sciences research in developing regions is creating a plethora of development opportunities for companies involved in this sector. Additionally, the introduction of innovative technological products and the increasing preference for efficient product delivery mechanisms are acting as catalysts for market growth. Label-free detection methods allow for the exploration of molecular interactions without the limitations associated with traditional labeling, such as quenching effects, spatial interference, or autofluorescence, making these technologies an attractive option in high throughput screening applications.

Restraints in the Global Label Free Detection Market

The global label-free detection market faces notable constraints that may impede its growth. A primary challenge is the elevated cost of the instruments required for label-free detection, which can deter potential users and limit market adoption. Additionally, the lack of awareness regarding the benefits and applications of label-free detection technologies further contributes to the market's slow expansion. This combination of high financial barriers and insufficient understanding hinders the market's ability to reach its full potential, preventing broader integration and acceptance of label-free detection methods across various sectors. Addressing these issues is crucial for facilitating market growth.

Market Trends of the Global Label Free Detection Market

The Global Label-Free Detection market is experiencing robust growth driven by technological innovations and strategic collaborations. Key techniques like bio-layer interferometry (BLI) and surface plasmon resonance (SPR) are gaining traction, with advancements such as Corning(R) Epic(R) BT leading the charge. This cutting-edge benchtop model streamlines cell-based and biochemical assays, boasts a competitive price, and features user-friendly data collection software, enabling greater accessibility for researchers, including those in academic settings. Partnerships, notably between Corning and Advinus Therapeutics, enhance market reach by facilitating drug discovery processes and assay services globally. As a result, the Label-Free Detection market is poised for significant expansion during the forecast period.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2023
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technological Advancement
• Regulatory Landscape
• Patent Analysis
• Case Studies

Global Label Free Detection Market Size by Product & CAGR (2024-2031)

• Market Overview
• Consumables
  • Biosensor Chips
  • Microplates
• Instruments

Global Label Free Detection Market Size by Technology & CAGR (2024-2031)

• Market Overview
• Bio-Layer Interferometry
• Differential Scanning Calorimetry
• Isothermal Titration Calorimetry
• Surface Plasmon Resonance
• Mass Spectrometry
• Other LFD Technologies

Global Label Free Detection Market Size by Application & CAGR (2024-2031)

• Market Overview
• Binding Kinetics
• Binding Thermodynamics
• Endogenous Receptor Detection
• Hit Confirmation
• Lead Generation
• Other

Global Label Free Detection Market Size by End-User & CAGR (2024-2031)

• Market Overview
• Pharmaceutical & Biotechnology Companies
• Academic & Research Institutes
• Contract Research Organizations

Global Label Free Detection Market Size & CAGR (2024-2031)

• North America (Product, Technology, Application, End-User)
  • USA
  • Canada
• Europe (Product, Technology, Application, End-User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Technology, Application, End-User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Technology, Application, End-User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Technology, Application, End-User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Agilent Technologies, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GE Healthcare (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Horiba, Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Malvern Panalytical Ltd. (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bruker Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Waters Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shimadzu Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Corning Incorporated (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hitachi High-Tech Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Molecular Devices, LLC (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sartorius AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BiOptix Analytical LLC (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Attana AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• XanTec Bioanalytics GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations